Mechanistically, we found an upregulation of the transcription factor FoxO1 in all three examined bladder cancer cell lines upon epigenetic treatment with DAC, ENT, or the combination of DAC plus ENT. The gene discussed is FOXO1; the disease is urinary bladder cancer.